Pregnancy in type 2B VWD: A case series

Haemophilia

Volumn 18, Issue 3, 2012, Pages 406-412

  Ranger, A ^a   Manning, R A ^a   Lyall, H ^b   Laffan, M A ^c   Millar, C M ^c  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Desmopressin; Factor VIII concentrate; Pregnancy; Thrombocytopenia; Von Willebrand disease

Indexed keywords

ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 8 CONCENTRATE; DESMOPRESSIN; ENOXAPARIN; TRANEXAMIC ACID; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLEEDING; CASE REPORT; CHILD; COMPRESSION GARMENT; EPISTAXIS; FEMALE; GENE MUTATION; GENE SEQUENCE; GENOTYPE; GESTATIONAL AGE; HEMOSTASIS; HETEROZYGOSITY; HUMAN; MENORRHAGIA; PERINATAL PERIOD; PHENOTYPE; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY OUTCOME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERAL INFECTION; PUERPERIUM; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; VON WILLEBRAND DISEASE;

ADULT; CESAREAN SECTION; COAGULANTS; FACTOR VIII; FEMALE; HEMOSTASIS; HUMANS; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND FACTOR;

EID: 84860324065     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02691.x     Document Type: Article

References (19)

1. Federici AB, Mannucci PM, Castaman G et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood 2009; 113: 526-34.
2. Lee CA, Chi C, Pavord SR et al. The obstetric and gynaecological management of women with inherited bleeding disorders - review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors' Organization. Haemophilia 2006; 12: 301-36.
3. Walker ID, Walker JJ, Colvin BT, Letsky EA, Rivers R, Stevens R. Investigation and management of haemorrhagic disorders in pregnancy. Haemostasis and Thrombosis Task Force. J Clin Pathol 1994; 47: 100-8.
4. Pasi KJ, Collins PW, Keeling DM et al. Management of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia 2004; 10: 218-31.
5. Pacheco LD, Costantine MM, Saade GR, Mucowski S, Hankins GD, Sciscione AC. von Willebrand disease and pregnancy: a practical approach for the diagnosis and treatment. Am J Obstet Gynecol 2010; 203: 194-200.
6. Nurden P, Gobbi G, Nurden A et al. Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood 2010; 115: 2649-56.
7. Ruggeri ZM. Type IIB von Willebrand disease: a paradox explains how von Willebrand factor works. J Thromb Haemost 2004; 2: 2-6.
8. Castaman G, Tosetto A, Rodeghiero F. Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations. Haematologica 2009; 95: 963-9.
9. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Pregnancy in von Willebrand's disease. J Clin Pathol 1994; 47: 569-70.
10. Rick ME, Williams SB, Sacher RA, McKeown LP. Thrombocytopenia associated with pregnancy in a patient with type IIB von Willebrand's disease. Blood 1987; 69: 786-9.
11. Casonato A, Sartori MT, Bertomoro A, Fede T, Vasoin F, Girolami A. Pregnancy-induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease. Blood Coagul Fibrinolysis 1991; 2: 33-40.
12. Giles AR, Hoogendoorn H, Benford K. Type IIB von Willebrand's disease presenting as thrombocytopenia during pregnancy. Br J Haematol 1987; 67: 349-53.
13. Morrison R, Crawford J, MacPherson M, Heptinstall S. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension. Thromb Haemost 1985; 54: 607-11.
14. Karalis I, Nadar SK, Al Yemeni E, Blann AD, Lip GY. Platelet activation in pregnancy-induced hypertension. Thromb Res 2005; 116: 377-83.
15. Brenner B, Zwang E, Bronshtein M, Seligsohn U. von Willebrand factor multimer patterns in pregnancy-induced hypertension. Thromb Haemost 1989; 62: 715-7.
16. Sanchez-Luceros A, Farias CE, Amaral MM et al. von Willebrand factor-cleaving protease (ADAMTS13) activity in normal non-pregnant women, pregnant and post-delivery women. Thromb Haemost 2004; 92: 1320-6.
17. Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood 2001; 98: 2730-5.
18. Feys HB, Deckmyn H, Vanhoorelbeke K. ADAMTS13 in health and disease. Acta Haematol 2009; 121: 183-5.
19. Golder M, Pruss CM, Hegadorn C et al. Mutation-specific hemostatic variability in mice expressing common type 2B von Willebrand disease substitutions. Blood 2010; 115: 4862-9.